Previous studies have shown that advanced liver fibrosis, male gender, older age, high AFP levels, greater alcohol intake, complications from diabetes mellitus, and obesity were risk factors for HCC development after HCV eradication by IFN treatment [17,18, 31–34]. Here, IFNA1 is linked to obesity due to melanocortin 4 receptor deficiency.